{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T09:00:24Z","timestamp":1790240424255,"version":"4.1.0"},"reference-count":125,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":13,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000771","name":"Prostate Cancer UK","doi-asserted-by":"publisher","award":["RIA18-ST2-022 MA-TIA22-005"],"award-info":[{"award-number":["RIA18-ST2-022 MA-TIA22-005"]}],"id":[{"id":"10.13039\/501100000771","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0373"],"award-info":[{"award-number":["W81XWH-20-1-0373"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-21-1-0850"],"award-info":[{"award-number":["W81XWH-21-1-0850"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Health Cancer Center","award":["P30CA022453"],"award-info":[{"award-number":["P30CA022453"]}]},{"DOI":"10.13039\/100017302","name":"Karmanos Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017302","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["R01CA220327"],"award-info":[{"award-number":["R01CA220327"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","award":["R01CA271750"],"award-info":[{"award-number":["R01CA271750"]}],"id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>ATP-dependent chromatin remodelers (ACRs) have emerged as central determinants of prostate cancer (PCa) progression and therapy resistance. Organized into 4 mechanistically distinct families (SWI\/SNF, ISWI, CHD, and INO80\/SWR), ACRs govern nucleosome positioning genome-wide and thereby occupy a central position in the epigenomic regulatory landscape that dictates where and when transcription factors, including the androgen receptor (AR), can engage chromatin. This review discusses ACR dysregulation in PCa through both mutational and non-mutational mechanisms. These are illustrated by discussing how the functional consequences are highly context-dependent, varying with disease stage, prior treatment exposure, and tumor ancestry. Loss of each of the tumor suppressors RB1, TP53, and PTEN generates specific ACR dependencies that are potentially therapeutically exploitable, including synthetic lethal relationships between PTEN deficiency and SWI\/SNF ATPase activity. Across the spectrum of AR signaling states, from hormone-sensitive disease through therapy-resistant neuroendocrine and double-negative PCa subtypes, ACR complex composition and genomic targeting are continuously reprogrammed to enable and sustain lineage plasticity and endocrine therapy escape. Therapeutic strategies targeting SWI\/SNF, ISWI, and INO80\/SWR complexes are at varying stages of preclinical and clinical development and are attractive novel avenues to target therapy-resistant PCa.<\/jats:p>","DOI":"10.1210\/endocr\/bqag103","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:55:00Z","timestamp":1789127700000},"source":"Crossref","is-referenced-by-count":0,"title":["ATP-dependent chromatin remodelers in prostate cancer progression and therapeutic resistance"],"prefix":"10.1210","volume":"167","author":[{"given":"Lillian M","family":"Torres","sequence":"first","affiliation":[{"name":"Department of Urology, Cedars-Sinai Health Sciences University , Los Angeles, CA 90048 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton","family":"Yates","sequence":"additional","affiliation":[{"name":"Department of Pathology, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]},{"name":"Department of Oncology Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine , Baltimore, MD 21287 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L","family":"Bevan","sequence":"additional","affiliation":[{"name":"Department of Surgery and Cancer, Imperial College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Freeman","sequence":"additional","affiliation":[{"name":"Department of Urology, Cedars-Sinai Health Sciences University , Los Angeles, CA 90048 ,","place":["USA"]},{"name":"Department of Biomedical Sciences, Cedars-Sinai Health Sciences University , Los Angeles, CA 90048 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3355-0928","authenticated-orcid":false,"given":"Moray J","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Oncology, Karmanos Cancer Institute, Wayne State School of Medicine , Detroit, MI 48201 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"2","key":"2026092404081426800_bqag103-B1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0092-8674(04)00044-3","article-title":"The nucleosome: from genomic organization to genomic regulation","volume":"116","author":"Khorasanizadeh","year":"2004","journal-title":"Cell"},{"issue":"6322","key":"2026092404081426800_bqag103-B2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1126\/science.aam5403","article-title":"Unlocking the nucleosome","volume":"355","author":"Flaus","year":"2017","journal-title":"Science"},{"issue":"19","key":"2026092404081426800_bqag103-B3","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1016\/j.molcel.2025.08.029","article-title":"A needed nomenclature for nucleosomes","volume":"85","author":"Keogh","year":"2025","journal-title":"Mol Cell"},{"key":"2026092404081426800_bqag103-B4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-1-61779-612-8_5","article-title":"DNA methylation in promoter region as biomarkers in prostate cancer","volume":"863","author":"Yang","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"8","key":"2026092404081426800_bqag103-B5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41588-020-0648-8","article-title":"The DNA methylation landscape of advanced prostate cancer","volume":"52","author":"Zhao","year":"2020","journal-title":"Nat Genet"},{"issue":"5","key":"2026092404081426800_bqag103-B6","doi-asserted-by":"crossref","first-page":"R267","DOI":"10.1530\/ERC-19-0032","article-title":"Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers","volume":"26","author":"Stelloo","year":"2019","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2026092404081426800_bqag103-B7","doi-asserted-by":"crossref","first-page":"21.29.1","DOI":"10.1002\/0471142727.mb2129s109","article-title":"ATAC-seq: a method for assaying chromatin accessibility genome-wide","volume":"109","author":"Buenrostro","year":"2015","journal-title":"Curr Protoc Mol Biol"},{"issue":"2","key":"2026092404081426800_bqag103-B8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ng.3734","article-title":"Dynamics of BAF-Polycomb complex opposition on heterochromatin in normal and oncogenic states","volume":"49","author":"Kadoch","year":"2017","journal-title":"Nat Genet"},{"issue":"12","key":"2026092404081426800_bqag103-B9","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1101\/gr.143008.112","article-title":"Genome-wide mapping of nucleosome positioning and DNA methylation within individual DNA molecules","volume":"22","author":"Kelly","year":"2012","journal-title":"Genome Res"},{"issue":"5762","key":"2026092404081426800_bqag103-B10","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1126\/science.1124000","article-title":"Histone H4-K16 acetylation controls chromatin structure and protein interactions","volume":"311","author":"Shogren-Knaak","year":"2006","journal-title":"Science"},{"issue":"2","key":"2026092404081426800_bqag103-B11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0092-8674(81)90056-8","article-title":"SV40 gene expression is modulated by the cooperative binding of T antigen to DNA","volume":"25","author":"Myers","year":"1981","journal-title":"Cell"},{"issue":"1","key":"2026092404081426800_bqag103-B12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/genetics\/98.1.25","article-title":"MUTANTS OF YEAST DEFECTIVE IN SUCROSE UTILIZATION","volume":"98","author":"Carlson","year":"1981","journal-title":"Genetics"},{"issue":"1","key":"2026092404081426800_bqag103-B13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/genetics\/98.1.41","article-title":"GENETIC EVIDENCE FOR A SILENT SUC GENE IN YEAST","volume":"98","author":"Carlson","year":"1981","journal-title":"Genetics"},{"issue":"1","key":"2026092404081426800_bqag103-B14","first-page":"49","article-title":"Cloning and genetic mapping of SNF1, a gene required for expression of glucose-repressible genes in Saccharomyces cerevisiae","volume":"4","author":"Celenza","year":"1984","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2026092404081426800_bqag103-B15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/0022-2836(84)90315-2","article-title":"Five SWI genes are required for expression of the HO gene in yeast","volume":"178","author":"Stern","year":"1984","journal-title":"J Mol Biol"},{"issue":"3","key":"2026092404081426800_bqag103-B16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(92)90192-F","article-title":"Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription","volume":"68","author":"Peterson","year":"1992","journal-title":"Cell"},{"issue":"6451","key":"2026092404081426800_bqag103-B17","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/366170a0","article-title":"BRG1 contains a conserved domain of the SWI2\/SNF2 family necessary for normal mitotic growth and transcription","volume":"366","author":"Khavari","year":"1993","journal-title":"Nature"},{"issue":"4","key":"2026092404081426800_bqag103-B18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1101\/gad.7.4.583","article-title":"The yeast SNF2\/SWI2 protein has DNA-stimulated ATPase activity required for transcriptional activation","volume":"7","author":"Laurent","year":"1993","journal-title":"Genes Dev"},{"issue":"6489","key":"2026092404081426800_bqag103-B19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/370477a0","article-title":"Nucleosome disruption and enhancement of activator binding by a human SW1\/SNF complex","volume":"370","author":"Kwon","year":"1994","journal-title":"Nature"},{"issue":"3","key":"2026092404081426800_bqag103-B20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.cell.2013.07.011","article-title":"Mechanisms and functions of ATP-dependent chromatin-remodeling enzymes","volume":"154","author":"Narlikar","year":"2013","journal-title":"Cell"},{"issue":"10","key":"2026092404081426800_bqag103-B21","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1093\/nar\/gkl295","article-title":"Identification of multiple distinct Snf2 subfamilies with conserved structural motifs","volume":"34","author":"Flaus","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2026092404081426800_bqag103-B22","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.biochem.77.062706.153223","article-title":"The biology of chromatin remodeling complexes","volume":"78","author":"Clapier","year":"2009","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"2026092404081426800_bqag103-B23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41580-023-00683-y","article-title":"Energy-driven genome regulation by ATP-dependent chromatin remodellers","volume":"25","author":"Eustermann","year":"2024","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"2026092404081426800_bqag103-B24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41588-023-01603-8","article-title":"The BAF chromatin remodeler synergizes with RNA polymerase II and transcription factors to evict nucleosomes","volume":"56","author":"Brahma","year":"2024","journal-title":"Nat Genet"},{"issue":"1","key":"2026092404081426800_bqag103-B25","doi-asserted-by":"crossref","first-page":"15616","DOI":"10.1038\/ncomms15616","article-title":"INO80 exchanges H2A.Z for H2A by translocating on DNA proximal to histone dimers","volume":"8","author":"Brahma","year":"2017","journal-title":"Nat Commun"},{"issue":"6","key":"2026092404081426800_bqag103-B26","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41588-024-01767-x","article-title":"Systematic assessment of ISWI subunits shows that NURF creates local accessibility for CTCF","volume":"56","author":"Iurlaro","year":"2024","journal-title":"Nat Genet"},{"issue":"8","key":"2026092404081426800_bqag103-B27","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1158\/2159-8290.CD-23-0225","article-title":"The transcriptional and epigenetic landscape of cancer cell lineage plasticity","volume":"13","author":"Davies","year":"2023","journal-title":"Cancer Discov"},{"issue":"4","key":"2026092404081426800_bqag103-B28","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/ng.545","article-title":"Nucleosome dynamics define transcriptional enhancers","volume":"42","author":"He","year":"2010","journal-title":"Nat Genet"},{"key":"2026092404081426800_bqag103-B29","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3389\/fonc.2019.01287","article-title":"Genomic alteration burden in advanced prostate cancer and therapeutic implications","volume":"9","author":"Ryan","year":"2019","journal-title":"Front Oncol"},{"issue":"5","key":"2026092404081426800_bqag103-B30","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","article-title":"The long tail of oncogenic drivers in prostate cancer","volume":"50","author":"Armenia","year":"2018","journal-title":"Nat Genet"},{"issue":"11","key":"2026092404081426800_bqag103-B31","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.110109","article-title":"Reduced NCOR2 expression accelerates androgen deprivation therapy failure in prostate cancer","volume":"37","author":"Long","year":"2021","journal-title":"Cell Rep"},{"issue":"6611","key":"2026092404081426800_bqag103-B32","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1126\/science.abn0478","article-title":"Lineage plasticity in prostate cancer depends on JAK\/STAT inflammatory signaling","volume":"377","author":"Chan","year":"2022","journal-title":"Science"},{"issue":"1","key":"2026092404081426800_bqag103-B33","doi-asserted-by":"crossref","first-page":"5345","DOI":"10.1038\/s41467-022-32701-6","article-title":"Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticity","volume":"13","author":"Westbrook","year":"2022","journal-title":"Nat Commun"},{"issue":"11","key":"2026092404081426800_bqag103-B34","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1158\/2767-9764.CRC-23-0250","article-title":"Concurrent targeting of HDAC and PI3K to overcome phenotypic heterogeneity of castration-resistant and neuroendocrine prostate cancers","volume":"3","author":"Zhang","year":"2023","journal-title":"Cancer Res Commun"},{"issue":"17","key":"2026092404081426800_bqag103-B35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI175217","article-title":"Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer","volume":"134","author":"Ku","year":"2024","journal-title":"J Clin Invest"},{"key":"2026092404081426800_bqag103-B36","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.963007","article-title":"To bind or not to bind: cistromic reprogramming in prostate cancer","volume":"12","author":"Shen","year":"2022","journal-title":"Front Oncol"},{"issue":"6764","key":"2026092404081426800_bqag103-B37","doi-asserted-by":"crossref","DOI":"10.1126\/science.adv2367","article-title":"Divergent FOXA1 mutations drive prostate tumorigenesis and therapy-resistant cellular plasticity","volume":"389","author":"Eyunni","year":"2025","journal-title":"Science"},{"issue":"11","key":"2026092404081426800_bqag103-B38","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1158\/2159-8290.CD-23-0331","article-title":"Transposable elements are co-opted as oncogenic regulatory elements by lineage-specific transcription factors in prostate cancer","volume":"13","author":"Grillo","year":"2023","journal-title":"Cancer Discov"},{"issue":"18","key":"2026092404081426800_bqag103-B39","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1158\/0008-5472.CAN-24-0890","article-title":"An atlas of accessible chromatin in advanced prostate cancer reveals the epigenetic evolution during tumor progression","volume":"84","author":"Shrestha","year":"2024","journal-title":"Cancer Res"},{"issue":"7963","key":"2026092404081426800_bqag103-B40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41586-023-06085-6","article-title":"Mitotic bookmarking by SWI\/SNF subunits","volume":"618","author":"Zhu","year":"2023","journal-title":"Nature"},{"issue":"3","key":"2026092404081426800_bqag103-B41","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41588-020-00768-w","article-title":"Mammalian SWI\/SNF continuously restores local accessibility to chromatin","volume":"53","author":"Iurlaro","year":"2021","journal-title":"Nat Genet"},{"issue":"2","key":"2026092404081426800_bqag103-B42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pros.20521","article-title":"Aberrant expression of SWI\/SNF catalytic subunits BRG1\/BRM is associated with tumor development and increased invasiveness in prostate cancers","volume":"67","author":"Sun","year":"2007","journal-title":"Prostate"},{"issue":"1","key":"2026092404081426800_bqag103-B43","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1038\/s41598-018-20217-3","article-title":"High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer","volume":"8","author":"Guerrero-Mart\u00ednez","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"2026092404081426800_bqag103-B44","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1038\/s41467-020-19328-1","article-title":"Role of specialized composition of SWI\/SNF complexes in prostate cancer lineage plasticity","volume":"11","author":"Cyrta","year":"2020","journal-title":"Nat Commun"},{"issue":"4","key":"2026092404081426800_bqag103-B45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2022.12.018","article-title":"Human SMARCA5 is continuously required to maintain nucleosome spacing","volume":"83","author":"Bomber","year":"2023","journal-title":"Mol Cell"},{"issue":"10","key":"2026092404081426800_bqag103-B46","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1016\/j.immuni.2025.09.002","article-title":"Control of myeloid lineage fidelity and response to stimuli by ISWI-enforced nucleosome phasing","volume":"58","author":"Polletti","year":"2025","journal-title":"Immunity"},{"issue":"11","key":"2026092404081426800_bqag103-B47","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/s41419-024-07117-3","article-title":"USP3 promotes DNA damage response and chemotherapy resistance through stabilizing and deubiquitinating SMARCA5 in prostate cancer","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis"},{"issue":"11","key":"2026092404081426800_bqag103-B48","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1158\/2159-8290.CD-25-0629","article-title":"Off-pore nucleoporin sPOM121 transcriptionally propels \u03b2-catenin-driven tumor progression and immune escape in prostate cancer","volume":"15","author":"Kirthika","year":"2025","journal-title":"Cancer Discov"},{"issue":"1","key":"2026092404081426800_bqag103-B49","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41467-025-67329-9","article-title":"BPTF regulates androgen receptor activity by enhancing chromatin accessibility and stabilizing the AR-FOXA1 interaction","volume":"17","author":"Jeon","year":"2025","journal-title":"Nat Commun"},{"issue":"4","key":"2026092404081426800_bqag103-B50","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/2767-9764.CRC-22-0389","article-title":"African American prostate cancer displays quantitatively distinct vitamin D receptor cistrome-transcriptome relationships regulated by BAZ1A","volume":"3","author":"Siddappa","year":"2023","journal-title":"Cancer Res Commun"},{"issue":"15","key":"2026092404081426800_bqag103-B51","doi-asserted-by":"crossref","first-page":"19908","DOI":"10.18632\/aging.203408","article-title":"A circular RNA, circSMARCA5, inhibits prostate cancer proliferative, migrative, and invasive capabilities via the miR-181b-5p\/miR-17-3p-TIMP3 axis","volume":"13","author":"Xie","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"5","key":"2026092404081426800_bqag103-B52","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkag138","article-title":"Recognition and remodelling of nucleosomes and hexasomes by the human INO80 complex","volume":"54","author":"Aggarwal","year":"2026","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"2026092404081426800_bqag103-B53","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1038\/s44318-025-00580-4","article-title":"The INO80 chromatin remodeller facilitates DNA damage bypass via postreplicative gap repair","volume":"44","author":"Wong","year":"2025","journal-title":"EMBO J"},{"issue":"1","key":"2026092404081426800_bqag103-B54","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1038\/s41467-020-18306-x","article-title":"Resolution of R-loops by INO80 promotes DNA replication and maintains cancer cell proliferation and viability","volume":"11","author":"Prendergast","year":"2020","journal-title":"Nat Commun"},{"key":"2026092404081426800_bqag103-B55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.dnarep.2018.12.007","article-title":"Mammalian INO80 chromatin remodeler cooperates with FANCM to mediate DNA interstrand crosslink-induced checkpoint activation and repair","volume":"74","author":"Andreev","year":"2019","journal-title":"DNA Repair (Amst)"},{"issue":"17","key":"2026092404081426800_bqag103-B56","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1111\/febs.14615","article-title":"The chromatin remodeling protein INO80 contributes to the removal of H2A.Z at the p53-binding site of the p21 gene in response to doxorubicin","volume":"285","author":"Ding","year":"2018","journal-title":"FEBS J"},{"issue":"1","key":"2026092404081426800_bqag103-B57","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s42003-022-03385-x","article-title":"PGC1 alpha coactivates ERG fusion to drive antioxidant target genes under metabolic stress","volume":"5","author":"Dhara","year":"2022","journal-title":"Commun Biol"},{"issue":"16","key":"2026092404081426800_bqag103-B58","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1016\/j.molcel.2025.07.013","article-title":"Ubiquitination of the histone variant mH2A1.2 prevents toxic RAD18 accumulation at a subset of genomic loci upon replication stress","volume":"85","author":"Galloy","year":"2025","journal-title":"Mol Cell"},{"issue":"4","key":"2026092404081426800_bqag103-B59","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ccell.2020.03.001","article-title":"Loss of CHD1 promotes heterogeneous mechanisms of resistance to AR-targeted therapy via chromatin dysregulation","volume":"37","author":"Zhang","year":"2020","journal-title":"Cancer Cell"},{"issue":"7","key":"2026092404081426800_bqag103-B60","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/1541-7786.MCR-20-0913","article-title":"MAP3K7 loss drives enhanced androgen signaling and independently confers risk of recurrence in prostate cancer with joint loss of CHD1","volume":"19","author":"Jillson","year":"2021","journal-title":"Mol Cancer Res"},{"issue":"5","key":"2026092404081426800_bqag103-B61","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1042\/BST20230070","article-title":"How does CHD4 slide nucleosomes?","volume":"52","author":"Reid","year":"2024","journal-title":"Biochem Soc Trans"},{"issue":"1","key":"2026092404081426800_bqag103-B62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-pharmtox-052220-015912","article-title":"A new old target: androgen receptor signaling and advanced prostate cancer","volume":"62","author":"Westaby","year":"2022","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"41","key":"2026092404081426800_bqag103-B63","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1038\/s41388-025-03573-z","article-title":"Evolving roles for the androgen receptor and its protein interactome in castration-resistant prostate cancer","volume":"44","author":"Chukhu","year":"2025","journal-title":"Oncogene"},{"issue":"7893","key":"2026092404081426800_bqag103-B64","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-021-04246-z","article-title":"Targeting SWI\/SNF ATPases in enhancer-addicted prostate cancer","volume":"601","author":"Xiao","year":"2022","journal-title":"Nature"},{"issue":"12_Suppl","key":"2026092404081426800_bqag103-B65","doi-asserted-by":"crossref","first-page":"A056","DOI":"10.1158\/1535-7163.TARG-23-A056","article-title":"Abstract A056: treatment with dual BRG1\/BRM (SMARCA4\/2) inhibitor FHD-286 ablates tumor-associated androgen response elements (AREs) in prostate cancer","volume":"22","author":"Sandoval","year":"2023","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"2026092404081426800_bqag103-B66","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1158\/0008-5472.CAN-07-6392","article-title":"Targeting the BAF57 SWI\/SNF subunit in prostate cancer: a novel platform to control androgen receptor activity","volume":"68","author":"Link","year":"2008","journal-title":"Cancer Res"},{"issue":"4","key":"2026092404081426800_bqag103-B67","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41391-025-00949-w","article-title":"Racial variation in the advanced prostate cancer genome","volume":"28","author":"Feng","year":"2025","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"2026092404081426800_bqag103-B68","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.molcel.2018.06.040","article-title":"Binding of TMPRSS2-ERG to BAF chromatin remodeling complexes mediates prostate oncogenesis","volume":"71","author":"Sandoval","year":"2018","journal-title":"Mol Cell"},{"issue":"4","key":"2026092404081426800_bqag103-B69","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","author":"Cancer Genome Atlas Research Network","year":"2015","journal-title":"Cell"},{"issue":"4","key":"2026092404081426800_bqag103-B70","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ccell.2019.03.001","article-title":"CHD1 loss alters AR binding at lineage-specific enhancers and modulates distinct transcriptional programs to drive prostate tumorigenesis","volume":"35","author":"Augello","year":"2019","journal-title":"Cancer Cell"},{"issue":"10","key":"2026092404081426800_bqag103-B71","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147878","article-title":"Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer","volume":"131","author":"Liu","year":"2021","journal-title":"J Clin Invest"},{"issue":"7642","key":"2026092404081426800_bqag103-B72","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature21357","article-title":"Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer","volume":"542","author":"Zhao","year":"2017","journal-title":"Nature"},{"issue":"37","key":"2026092404081426800_bqag103-B73","doi-asserted-by":"crossref","first-page":"4164","DOI":"10.1038\/onc.2011.590","article-title":"Recurrent deletion of CHD1 in prostate cancer with relevance to cell invasiveness","volume":"31","author":"Huang","year":"2012","journal-title":"Oncogene"},{"issue":"16","key":"2026092404081426800_bqag103-B74","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/pros.24218","article-title":"SPOP and CHD1 alterations in prostate cancer: relationship with PTEN loss, tumor grade, perineural infiltration, and PSA recurrence","volume":"81","author":"Hern\u00e1ndez-Llodr\u00e0","year":"2021","journal-title":"Prostate"},{"issue":"1","key":"2026092404081426800_bqag103-B75","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41417-020-00288-z","article-title":"CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo","volume":"29","author":"Oh-Hohenhorst","year":"2022","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"2026092404081426800_bqag103-B76","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41698-024-00705-8","article-title":"Frequent CHD1 deletions in prostate cancers of African American men is associated with rapid disease progression","volume":"8","author":"Diossy","year":"2024","journal-title":"NPJ Precis Oncol"},{"issue":"35","key":"2026092404081426800_bqag103-B77","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1038\/onc.2011.554","article-title":"Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer","volume":"31","author":"Liu","year":"2012","journal-title":"Oncogene"},{"issue":"9","key":"2026092404081426800_bqag103-B78","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1158\/0008-5472.CAN-12-1342","article-title":"CHD1 is a 5q21 tumor suppressor required for ERG rearrangement in prostate cancer","volume":"73","author":"Burkhardt","year":"2013","journal-title":"Cancer Res"},{"issue":"5","key":"2026092404081426800_bqag103-B79","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/s43018-025-00952-z","article-title":"CHD1 loss reprograms SREBP2-driven cholesterol synthesis to fuel androgen-responsive growth and castration resistance in SPOP-mutated prostate tumors","volume":"6","author":"Chen","year":"2025","journal-title":"Nat Cancer"},{"key":"2026092404081426800_bqag103-B80","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2026.101289","article-title":"Genetic loss of CHD1 regulates distinct histone post-translational modifications in the development of castration-resistant prostate cancer","volume":"73","author":"Purohit","year":"2026","journal-title":"Neoplasia"},{"issue":"6","key":"2026092404081426800_bqag103-B81","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41416-025-02944-3","article-title":"Loss of ARID1A accelerates prostate tumourigenesis with a proliferative collagen-poor phenotype through co-operation with AP1 subunit cFos","volume":"132","author":"Hartley","year":"2025","journal-title":"Br J Cancer"},{"issue":"1","key":"2026092404081426800_bqag103-B82","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1038\/s41467-022-34871-9","article-title":"ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression","volume":"13","author":"Li","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"2026092404081426800_bqag103-B83","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2012.11.010","article-title":"The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man","volume":"23","author":"Sharma","year":"2013","journal-title":"Cancer Cell"},{"issue":"7794","key":"2026092404081426800_bqag103-B84","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41586-020-1930-8","article-title":"Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer","volume":"578","author":"Faivre","year":"2020","journal-title":"Nature"},{"issue":"4","key":"2026092404081426800_bqag103-B85","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1158\/0008-5472.CAN-20-1417","article-title":"BRD9 is a critical regulator of androgen receptor signaling and prostate cancer progression","volume":"81","author":"Alpsoy","year":"2021","journal-title":"Cancer Res"},{"issue":"1","key":"2026092404081426800_bqag103-B86","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molcel.2008.01.018","article-title":"The double bromodomain proteins Brd2 and Brd3 couple histone acetylation to transcription","volume":"30","author":"LeRoy","year":"2008","journal-title":"Mol Cell"},{"key":"2026092404081426800_bqag103-B87","doi-asserted-by":"crossref","first-page":"01","DOI":"10.12703\/P7-01","article-title":"H2a.Z: a molecular rheostat for transcriptional control","volume":"7","author":"Subramanian","year":"2015","journal-title":"F1000Prime Rep"},{"issue":"7","key":"2026092404081426800_bqag103-B88","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nrm.2017.26","article-title":"Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes","volume":"18","author":"Clapier","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"2026092404081426800_bqag103-B89","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/sj.emboj.7601541","article-title":"Distinct mammalian SWI\/SNF chromatin remodeling complexes with opposing roles in cell-cycle control","volume":"26","author":"Nagl","year":"2007","journal-title":"EMBO J"},{"issue":"21","key":"2026092404081426800_bqag103-B90","doi-asserted-by":"crossref","first-page":"8282","DOI":"10.1158\/0008-5472.CAN-10-2205","article-title":"Transcriptional activation by pRB and its coordination with SWI\/SNF recruitment","volume":"70","author":"Flowers","year":"2010","journal-title":"Cancer Res"},{"key":"2026092404081426800_bqag103-B91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.redox.2018.05.017","article-title":"PARP1 promoter links cell cycle progression with adaptation to oxidative environment","volume":"18","author":"Pietrzak","year":"2018","journal-title":"Redox Biol"},{"issue":"52","key":"2026092404081426800_bqag103-B92","doi-asserted-by":"crossref","first-page":"37429","DOI":"10.1074\/jbc.M706039200","article-title":"The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI\/SNF chromatin remodeling complexes","volume":"282","author":"Xu","year":"2007","journal-title":"J Biol Chem"},{"issue":"12","key":"2026092404081426800_bqag103-B93","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1101\/gad.263202.115","article-title":"Mutant p53 cooperates with the SWI\/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells","volume":"29","author":"Pfister","year":"2015","journal-title":"Genes Dev"},{"issue":"13-14","key":"2026092404081426800_bqag103-B94","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1101\/gad.349249.121","article-title":"PBAF loss leads to DNA damage-induced inflammatory signaling through defective G2\/M checkpoint maintenance","volume":"36","author":"Feng","year":"2022","journal-title":"Genes Dev"},{"issue":"6320","key":"2026092404081426800_bqag103-B95","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"issue":"6320","key":"2026092404081426800_bqag103-B96","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.aah4307","article-title":"SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer","volume":"355","author":"Mu","year":"2017","journal-title":"Science"},{"issue":"1","key":"2026092404081426800_bqag103-B97","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1038\/s41467-026-71655-x","article-title":"RB loss modulates chromatin organization by regulating cohesin-dependent loops and enhancer-promoter interactions","volume":"17","author":"Lee","year":"2026","journal-title":"Nat Commun"},{"issue":"4","key":"2026092404081426800_bqag103-B98","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/0008-5472.CAN-25-2747","article-title":"EZH2 suppression diversifies prostate cancer lineage variant evolution and lacks efficacy in inhibiting disease progression","volume":"86","author":"Jacobi","year":"2026","journal-title":"Cancer Res"},{"issue":"3","key":"2026092404081426800_bqag103-B99","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nm.4045","article-title":"Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer","volume":"22","author":"Beltran","year":"2016","journal-title":"Nat Med"},{"issue":"24","key":"2026092404081426800_bqag103-B100","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1200\/JCO.2017.77.6880","article-title":"Clinical and genomic characterization of treatment-emergent small-cell neuroendocrine prostate cancer: a multi-institutional prospective study","volume":"36","author":"Aggarwal","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6","key":"2026092404081426800_bqag103-B101","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2013.11.012","article-title":"Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade","volume":"155","author":"Arora","year":"2013","journal-title":"Cell"},{"issue":"13","key":"2026092404081426800_bqag103-B102","doi-asserted-by":"crossref","first-page":"7740","DOI":"10.1093\/nar\/gkae547","article-title":"ONECUT2 acts as a lineage plasticity driver in adenocarcinoma as well as neuroendocrine variants of prostate cancer","volume":"52","author":"Qian","year":"2024","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"2026092404081426800_bqag103-B103","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1101\/gr.280224.124","article-title":"Androgen receptor\u2013mediated assisted loading of the glucocorticoid receptor modulates transcriptional responses in prostate cancer cells","volume":"35","author":"Hiltunen","year":"2025","journal-title":"Genome Res"},{"issue":"2","key":"2026092404081426800_bqag103-B104","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.neuron.2007.06.019","article-title":"An essential switch in subunit composition of a chromatin remodeling complex during neural development","volume":"55","author":"Lessard","year":"2007","journal-title":"Neuron"},{"issue":"1","key":"2026092404081426800_bqag103-B105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41420-026-03068-0","article-title":"SMARCA4 promotes lineage plasticity and enzalutamide resistance in prostate cancer by regulating PROX1 via H3K27 acetylation","volume":"12","author":"Wu","year":"2026","journal-title":"Cell Death Discov"},{"issue":"8","key":"2026092404081426800_bqag103-B106","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1038\/s41588-025-02265-4","article-title":"NKX2-1 drives neuroendocrine transdifferentiation of prostate cancer via epigenetic and 3D chromatin remodeling","volume":"57","author":"Lu","year":"2025","journal-title":"Nat Genet"},{"issue":"49","key":"2026092404081426800_bqag103-B107","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2500327122","article-title":"Distinct transcription factor interactions drive HOXB13 activity in different stages of prostate cancer","volume":"122","author":"Ersoy-Fazlioglu","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2026092404081426800_bqag103-B108","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s42003-024-07413-w","article-title":"Identification of selective SWI\/SNF dependencies in enzalutamide-resistant prostate cancer","volume":"8","author":"Gokbayrak","year":"2025","journal-title":"Commun Biol"},{"issue":"1","key":"2026092404081426800_bqag103-B109","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3390\/cells12010124","article-title":"The SMARCD family of SWI\/SNF accessory proteins is involved in the transcriptional regulation of androgen receptor-driven genes and plays a role in various essential processes of prostate cancer","volume":"12","author":"Ertl","year":"2022","journal-title":"Cells"},{"issue":"6596","key":"2026092404081426800_bqag103-B110","doi-asserted-by":"crossref","DOI":"10.1126\/science.abe1505","article-title":"Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets","volume":"376","author":"Tang","year":"2022","journal-title":"Science"},{"key":"2026092404081426800_bqag103-B111","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1158\/0008-5472.CAN-25-2928","article-title":"A double-negative prostate cancer subtype is vulnerable to SWI\/SNF-targeting degrader molecules","volume":"86","author":"Thienger","year":"2026","journal-title":"Cancer Res"},{"issue":"16","key":"2026092404081426800_bqag103-B112","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1158\/0008-5472.CAN-23-0593","article-title":"The genomic and epigenomic landscape of double-negative metastatic prostate cancer","volume":"83","author":"Lundberg","year":"2023","journal-title":"Cancer Res"},{"issue":"2","key":"2026092404081426800_bqag103-B113","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4161\/epi.3.2.6153","article-title":"Involvement of the chromatin-remodeling factor BRG1\/SMARCA4 in human cancer","volume":"3","author":"Medina","year":"2008","journal-title":"Epigenetics"},{"issue":"7406","key":"2026092404081426800_bqag103-B114","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"issue":"12","key":"2026092404081426800_bqag103-B115","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1158\/1078-0432.CCR-24-3790","article-title":"A phase I study of FHD-286, a dual BRG1\/BRM (SMARCA4\/SMARCA2) inhibitor, in patients with advanced myeloid malignancies","volume":"31","author":"DiNardo","year":"2025","journal-title":"Clin Cancer Res"},{"issue":"15","key":"2026092404081426800_bqag103-B116","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2322563121","article-title":"Development of an orally bioavailable mSWI\/SNF ATPase degrader and acquired mechanisms of resistance in prostate cancer","volume":"121","author":"He","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2026092404081426800_bqag103-B117","doi-asserted-by":"crossref","first-page":"15928","DOI":"10.1021\/acs.jmedchem.6c01093","article-title":"Discovery of SMD-6346: a potent, selective, and orally active SMARCA2 degrader for targeting SMARCA4-deficient human cancers","volume":"69","author":"Leng","year":"2026","journal-title":"J Med Chem"},{"issue":"4","key":"2026092404081426800_bqag103-B118","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1158\/1078-0432.CCR-24-2583","article-title":"A phase I study of FHD-609, a heterobifunctional degrader of bromodomain-containing protein 9, in patients with advanced synovial sarcoma or SMARCB1-deficient tumors","volume":"31","author":"Livingston","year":"2025","journal-title":"Clin Cancer Res"},{"key":"2026092404081426800_bqag103-B119","doi-asserted-by":"publisher","first-page":"OF1","DOI":"10.1158\/0008-5472.CAN-25-5405","article-title":"BRD9 degraders unleash GBAF chromatin remodeling activity in synovial sarcoma","author":"Li","year":"2026","journal-title":"Cancer Res"},{"issue":"1","key":"2026092404081426800_bqag103-B120","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ng.3165","article-title":"BAZ2A (TIP5) is involved in epigenetic alterations in prostate cancer and its overexpression predicts disease recurrence","volume":"47","author":"Gu","year":"2015","journal-title":"Nat Genet"},{"issue":"11","key":"2026092404081426800_bqag103-B121","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153014","article-title":"BAZ2A-mediated repression via H3K14ac-marked enhancers promotes prostate cancer stem cells","volume":"22","author":"Pe\u00f1a-Hern\u00e1ndez","year":"2021","journal-title":"EMBO Rep"},{"issue":"7","key":"2026092404081426800_bqag103-B122","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202301950","article-title":"BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer","volume":"6","author":"Roganowicz","year":"2023","journal-title":"Life Sci Alliance"},{"issue":"23","key":"2026092404081426800_bqag103-B123","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1128\/MCB.06182-11","article-title":"Mammalian Ino80 mediates double-strand break repair through its role in DNA end strand resection","volume":"31","author":"Gospodinov","year":"2011","journal-title":"Mol Cell Biol"},{"issue":"14","key":"2026092404081426800_bqag103-B124","doi-asserted-by":"crossref","first-page":"9074","DOI":"10.1093\/nar\/gku605","article-title":"The mammalian INO80 chromatin remodeling complex is required for replication stress recovery","volume":"42","author":"Vassileva","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"29","key":"2026092404081426800_bqag103-B125","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adm9577","article-title":"R-loop resolution by ARIP4 helicase promotes androgen-mediated transcription induction","volume":"10","author":"Ng","year":"2024","journal-title":"Sci Adv"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/endo\/advance-article-pdf\/doi\/10.1210\/endocr\/bqag103\/71123762\/bqag103.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/10\/bqag103\/71123762\/bqag103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/endo\/article-pdf\/167\/10\/bqag103\/71123762\/bqag103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T08:08:41Z","timestamp":1790237321000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/doi\/10.1210\/endocr\/bqag103\/8802192"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":125,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,9,3]]}},"URL":"https:\/\/doi.org\/10.1210\/endocr\/bqag103","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,9,3]]},"article-number":"bqag103"}}